Emerge Weight Loss vs Strut Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Emerge Weight Loss
Best for patients committed to tirzepatide as their drug of choiceStarting at $299/mo
Strut Health
Best for oral-lozenge compounded GLP-1 accessStarting at $99/mo
Side-by-Side Comparison
| Feature | Emerge Weight Loss | Strut Health |
|---|---|---|
| Overall Score | 7.6/10 | ✓8.1/10 |
| Starting Price | $299/mo | ✓$99/mo |
| Editorial Rating | 3.8 ★ /5 | ✓4.1 ★ /5 |
| Features | 4 features | ✓6 features |
| States Available | 0 | ✓49 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Emerge Weight Loss
Pros
- ✓Tirzepatide-focused (largest effect-size compounded GLP-1)
- ✓Wide dose range available
- ✓Physician-supervised telemedicine model
Cons
- ✗No semaglutide option — limits flexibility if tirzepatide tolerability is poor
- ✗Less brand recognition than Henry Meds, Mochi, or SkinnyRx
Strut Health
Pros
- ✓Both LegitScript and ACHC accreditation — pharmacy oversight standard most compounded GLP-1 providers don't advertise
- ✓Oral lozenge formulation available for semaglutide ($99/mo) and tirzepatide ($199/mo) — injection-free alternative
- ✓Transparent auto-refill pricing with 13–21% savings vs. one-off orders
- ✓Free unlimited follow-up messaging with board-certified US physicians
- ✓49 states covered (only Arkansas excluded as of September 2024)
Cons
- ✗'Medical necessity' eligibility gate — Strut's prescribers evaluate whether treatment is medically appropriate but the criteria are not publicly defined, so users can't self-screen before paying for a consultation
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — users can't independently verify 503A/503B compounding source
- ✗No insurance accepted — cash pay only
- ✗Phone consultation requirement varies by state (not every state mandates a synchronous visit)
Our Verdict
Strut Health edges out Emerge Weight Loss with a higher overall score of 8.1/10 and is particularly strong for oral-lozenge compounded GLP-1 access. Emerge Weight Loss remains a solid alternative, especially if you're looking for patients committed to tirzepatide as their drug of choice.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.